Quantcast

Latest Carpuject Stories

2009-10-08 11:14:00

LAKE FOREST, Ill., Oct. 8 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today signed a Business Cooperation Agreement with South Korea-based Celltrion, Inc. and Celltrion Healthcare, Inc. ("Celltrion"), which outlines the business terms of a future distribution agreement for the United States, Europe, Australia, New Zealand and Canada for eight biogeneric products that are currently under development by Celltrion, five of...

2009-09-28 13:09:00

LAKE FOREST, Ill., Sept. 28 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its third-quarter 2009 results on Tuesday, Oct. 27, 2009, at 8 a.m. Central time. (Logo: http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO) The company will release its third-quarter 2009 results earlier that morning, before the U.S. stock market open and the...

2009-09-16 14:41:00

LAKE FOREST, Ill., Sept. 16 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that the company will present at the UBS Global Life Sciences Conference on Wednesday, Sept. 23, 2009 in New York. The presentation is scheduled to begin at 8:30 a.m. Eastern time on Wednesday, Sept. 23, 2009. It will be available to all interested parties through a live audiocast accessible via the investor relations...

2009-09-10 14:49:00

LAKE FOREST, Ill., Sept. 10 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host its 2009 Investor Day event in downtown Chicago on Thursday, Sept. 17, 2009. The company's senior leadership team and additional members of management will be participating in the event. A streaming audio webcast of the event, together with the slide presentations, will be available on the Investor...

2009-08-31 15:45:00

LAKE FOREST, Ill., Aug. 31 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's applications for six new presentations of therapeutic heparin in single- and multiple-dose vials. Heparin is used to prevent clot formation in central venous catheters and for anticoagulant (blood thinning) therapy, and is available in numerous delivery systems for...

2009-08-11 10:29:00

LAKE FOREST, Ill., Aug. 11 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval and launch of oxaliplatin injection in the United States. The medication is a generic version of Sanofi-Aventis' Eloxatin(R), which posted 2008 U.S. sales of approximately $1.4 billion. Hospira's oxaliplatin injection is one of the first generic versions of this drug to come in solution form....

2009-06-30 09:22:00

LAKE FOREST, Ill., June 30 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced agreements with MedAssets on intravenous (I.V.) solutions and gravity I.V. equipment, and a renewal of its agreement for infusion devices. The five-year MedAssets agreements are effective as of June 1, 2009, for I.V. solutions and equipment, and July 1, 2009, for infusion devices. These new agreements represent a first for Hospira...

2009-06-29 10:41:00

LAKE FOREST, Ill., June 29 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for a 500 mg vial of azithromycin for injection in the ADD-Vantage(R) System. The anti-infective medication is a generic version of Pfizer's Zithromax(R) for injection. U.S. sales of generic and name-brand azithromycin for injection were approximately $40 million in 2008....

2009-06-26 09:06:00

LAKE FOREST, Ill., June 26 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its second-quarter 2009 results on Wednesday, July 29, 2009, at 8 a.m. Central time. The company will release its second-quarter 2009 results earlier that morning, before the U.S. stock market open and the conference call. A live webcast of the conference call will be...

2009-06-18 18:19:00

-- Has Tentative FDA Approval and Expects Final Approval Shortly -- LAKE FOREST, Ill., June 18 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced that the U.S. District Court for the District of New Jersey has granted summary judgment of non-infringement in Hospira's favor with regard to Sanofi Aventis' chemotherapy medication Eloxatin(R), and that Hospira has tentative approval from the U.S. Food and Drug...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related